Development of TLR5 agonist based approaches to boost chemo-immunotherapy by modulating immunosuppressive networks
-
Award Number: R21CA267274
-
ORGANIZATION: NATIONAL CANCER INSTITUTE
-
OPDIV: NIH
-
AWARD CLASS: DISCRETIONARY
-
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)